Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Other Non-Current Assets (2016 - 2026)

Iradimed has reported Other Non-Current Assets over the past 14 years, most recently at $225000.0 for Q1 2026.

  • Quarterly Other Non-Current Assets rose 9.22% to $225000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $225000.0 through Mar 2026, up 9.22% year-over-year, with the annual reading at $239000.0 for FY2025, 32.49% down from the prior year.
  • Other Non-Current Assets was $225000.0 for Q1 2026 at Iradimed, down from $239000.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $648672.0 in Q4 2022 and troughed at $172272.0 in Q1 2022.
  • The 5-year median for Other Non-Current Assets is $206009.0 (2025), against an average of $257219.0.
  • Year-over-year, Other Non-Current Assets skyrocketed 222.2% in 2022 and then plummeted 72.03% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $648672.0 in 2022, then plummeted by 72.03% to $181449.0 in 2023, then surged by 95.1% to $354000.0 in 2024, then tumbled by 32.49% to $239000.0 in 2025, then fell by 5.86% to $225000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Other Non-Current Assets are $225000.0 (Q1 2026), $239000.0 (Q4 2025), and $214374.0 (Q3 2025).